feed,title,long_url,short_url
SeekingAlpha,Kodiak Sciences CMO resigns following failed Phase 3 studies for lead drug,https://seekingalpha.com/news/4004194,
SeekingAlpha,Bond Market Expectations: II,https://seekingalpha.com/article/4629392,
SeekingAlpha,First Advantage: Uncertain Near-Term Macro Should Make The Stock Range Bound,https://seekingalpha.com/article/4629391,
